August 1, 2018 (Vol. 38, No. 14)

Expedeon

2view is a double-labeled, secondary antibody that enables extended detection within the widely used Western blot application. The product consists of a ternary complex developed using the company’s world-leading InnovaCoat and Lightning-Link technology. 2view secondary antibodies are labeled simultaneously with a visible chemi-luminescent enzymatic detection system. The gold nanoparticles enable fast visible detection at nanogram level whereas the enzymatic detection mechanism enhances sensitivity down to picogram levels of protein.